• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE American to Suspend Trading in BlueRiver Acquisition Corp. (BLUA)

    7/15/24 9:15:00 AM ET
    $BLUA
    Blank Checks
    Finance
    Get the next $BLUA alert in real time by email

    NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares (NYSE:BLUA) and units (NYSE:BLUA) of BlueRiver Acquisition Corp. (the "Company") from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company's listed securities, which included Company's Class A ordinary shares, units and redeemable warrants (collectively, "Securities"), and the Company appealed such delisting determination. On July 3, 2024, the NYSE American suspended trading in the Company's redeemable warrants as they were trading at an abnormally low selling price. On July 12, 2024, the Company withdrew its appeal. Accordingly, the NYSE American will now suspend trading in the Company's Class A ordinary shares and units and will apply with the Securities and Exchange Commission to delist the Company's Securities.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240715725589/en/

    Get the next $BLUA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLUA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLUA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by BlueRiver Acquisition Corp.

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/9/24 2:47:16 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by BlueRiver Acquisition Corp. (Amendment)

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      5/10/24 4:21:54 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by BlueRiver Acquisition Corp.

      SC 13G - BlueRiver Acquisition Corp. (0001831006) (Subject)

      3/11/24 7:49:12 PM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    SEC Filings

    See more
    • SEC Form 425 filed by BlueRiver Acquisition Corp.

      425 - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/6/24 4:54:23 PM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - BlueRiver Acquisition Corp. (0001831006) (Filer)

      8/6/24 4:51:44 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form DEF 14A filed by BlueRiver Acquisition Corp.

      DEF 14A - BlueRiver Acquisition Corp. (0001831006) (Filer)

      7/26/24 4:36:22 PM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NYSE American to Suspend Trading in BlueRiver Acquisition Corp. (BLUA)

      NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares (NYSE:BLUA) and units (NYSE:BLUA) of BlueRiver Acquisition Corp. (the "Company") from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company's listed securities, which included Company's Class A ordinary shares, units and redeemable warrants (collectively, "Securities"), and the Company appealed such delisting determination. On July 3, 2024, the NYSE American suspended trading in the Company's redeemable warrants as they were trading at an a

      7/15/24 9:15:00 AM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. Receives Commencement of Delisting Notice From NYSE American; Announces Extension of Merger Agreement

      BlueRiver Acquisition Corp. (NYSE:BLUA) (the "Company") announces that, as disclosed in the Company's Current Report on Form 8-K filed on February 7, 2024 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC ("NYSE American" or the "Exchange") on February 2, 2024, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company's Common Stock, Units and Rights (collectively, the "Securities") pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offe

      2/7/24 5:58:00 PM ET
      $BLUA
      Blank Checks
      Finance
    • Spinal Stabilization Technologies, LLC, a Leading Developer and Manufacturer of Spinal Medical Devices, to be Publicly Listed through a Proposed Business Combination with BlueRiver Acquisition Corp.

      Spinal Stabilization Technologies is a pioneer in developing minimally invasive surgical treatments for specific types of lower back pain. It is targeting a promising market opportunity within the areas of Augmented Discectomy and Degenerative Disc Disease. In March 2021, the FDA granted the PerQdisc Nucleus Replacement System, the Company's leading product candidate, designation as a Breakthrough Device, potentially allowing for a more streamlined FDA review process and reduced regulatory costs. Proposed transaction represents a pre-money equity value of $240 million for Spinal Stabilization Technologies. Existing Spinal Stabilization Technologies shareholders will roll 100% o

      7/24/23 5:04:00 AM ET
      $BLUA
      Blank Checks
      Finance